Mindfulness for Pain and Suicide
NCT05286112
Behavior, Behavioral Symptoms
Canandaigua, New York, United States
View Trial DetailsNCT Number: NCT06619171
Living with chronic pain can be tough for any young person. But while some young people may experience distressing thoughts, others may not. No young person should face these problems alone. So, it's important to better understand who might be more vulnerable to distress, when, and why. That way, healthcare professionals can be there for vulnerable youth when they need it most.
In total, 70 young people with chronic pain (aged 12-19 years) will be invited to take part. Over a 30-day period, they will answer a few questions about their pain and feelings five times per day (experience sampling part) and complete three detailed surveys (at the start, in the middle, and at the end).
This will help the investigators better understand how feelings of pain and distress might change over hours, days, and weeks. Plus, it might reveal which psychological and social factors might bring about these changes.
Answering these questions is vital as it will help healthcare professionals make sure vulnerable young people get the right care at the right time.
Interested in participating?
Request Info12 year–19 year
All sexes
Observational
Bath Centre for Pain Services [BCPS], Bath, United Kingdom
This study aims to address the following research questions:
Primary objective:
The investigators will use the repeated survey data (at day 0, 15, and 31):
Secondary objectives:
The investigators will use the experience sampling data (5x day/30 days: day 1-30) to explore:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: day 0 (baseline), 15 (interim survey), and day 31 (final survey)
Hopelessness Scale for Children (HSC; 17 items) Response options: 1=True, 0=False (total score range: 0-17) The higher the score, the greater the hopelessness for the future.
Time frame: day 0 (baseline), 15 (interim survey), and day 31 (final survey)
Short Defeat and Entrapment Scale (4 item entrapment subscale) Response options: 0 = not at all, 1 = a little bit, 2 = moderately, 3 = quite a bit, 4 = extremely like me (total score range: 0-16) Higher scores indicate greater feelings of entrapment.
Time frame: day 0 (baseline), 15 (interim survey), and day 31 (final survey)
10 separate items on the presence/ absence of suicidal and self-harm thoughts and behaviours.
Time frame: day 1 to 30
single item on hopelessness, assessed repeatedly (5x/30 days) via experience sampling (ESM) Response options: 1 (not at all) - 7 (very much). Higher scores indicate greater feelings of hopelessness
Time frame: day 1 to 30
single item on entrapment, assessed repeatedly (5x/30 days) via experience sampling (ESM).
Response options: 1 (not at all) - 7 (very much). Higher scores indicate greater feelings of entrapment.
Time frame: day 1 to 30
single items on suicidal and self-harm thoughts and behaviours (5x/30 days), assessed repeatedly via experience sampling (ESM)
University of Oxford
Other
Suicidal Distress in Adolescents With Chronic Pain: Who is at Risk, When, and Why?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05286112
Behavior, Behavioral Symptoms
Canandaigua, New York, United States
View Trial DetailsNCT06353100
Anxiety Disorders, Behavior
Santiago, RM, Chile
View Trial DetailsNCT04261114
Behavior, Behavioral Symptoms
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT07297901
Autonomic Nervous System, Brain Diseases
Phoenix, Arizona, United States
View Trial Details